These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing. Wang M; Escudero-Ibarz L; Moody S; Zeng N; Clipson A; Huang Y; Xue X; Grigoropoulos NF; Barrans S; Worrillow L; Forshew T; Su J; Firth A; Martin H; Jack A; Brugger K; Du MQ J Mol Diagn; 2015 Sep; 17(5):521-32. PubMed ID: 26165823 [TBL] [Abstract][Full Text] [Related]
13. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice. Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127 [TBL] [Abstract][Full Text] [Related]
14. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material. de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633 [TBL] [Abstract][Full Text] [Related]
15. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA]. Pécuchet N; Legras A; Laurent-Puig P; Blons H Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564 [TBL] [Abstract][Full Text] [Related]
16. MPD: multiplex primer design for next-generation targeted sequencing. Wingo TS; Kotlar A; Cutler DJ BMC Bioinformatics; 2017 Jan; 18(1):14. PubMed ID: 28056760 [TBL] [Abstract][Full Text] [Related]
17. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757 [TBL] [Abstract][Full Text] [Related]
18. Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Deeb KK; Hohman CM; Risch NF; Metzger DJ; Starostik P Arch Pathol Lab Med; 2015 Jul; 139(7):913-21. PubMed ID: 26125431 [TBL] [Abstract][Full Text] [Related]
19. MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels. Poirot B; Doucet L; Benhenda S; Champ J; Meignin V; Lehmann-Che J J Thorac Oncol; 2017 Oct; 12(10):1582-1587. PubMed ID: 28779874 [TBL] [Abstract][Full Text] [Related]
20. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory. Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]